Results

Protalix BioTherapeutics Inc.

05/29/2022 | Press release | Distributed by Public on 05/29/2022 00:56

Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal Function in Fabry Disease - 24-Month Results from the Phase III Randomized, Double-blind, BALANCE Study;[...]